A study of the effects of a test-food on aged physical functions
- Conditions
- Elderly male/female subjects
- Registration Number
- JPRN-UMIN000042947
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Not provided
(1) Subjects who will take steadily in the medicines (muscle-enhancing/anti-inflammation (over twice a week)/growth hormone/anti-dementia/anti-choline/sleeping pill/anti-fear/anti-depression/anti-mental disease/SGLT2-inhibitory/anti-Shenkui), which might affect the test results. (2) Subjects who have a habit of exercises, except taking a walk. (3) Subjects who have any difficulty in refraining from taking steadily (over once a week) in the health-specific/functional/supplementary/health foods, including amino acids and/or proteins, which might reveal some kind of effect for maintaining their muscle and muscular strength, and inhibiting a failure of those. (4) Subjects who are given a massage/chiropractic steadily (over once a week) and/or will be given those, which might affect the test results during test period. (5) Subjects with previous/present medical history of serious diseases in heart, liver, kidney and/or digestive organs. (6) Subjects who excessively take alcohol. (7) Subjects with extremely irregular eating habits and life rhythms, midnight work and/or irregular shift one. (8) Subjects with wheat allergy. (9) Subjects who are now under the other clinical test with a medicine/food, or took part in that within 4 weeks before this test, or will join that after giving informed consent to join this test. (10) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this test. (11) Males who donated over 400 mL of their whole blood within the last 3 months before this test. (12) Females who donated over 400 mL of their whole blood within the last 4 months before this test. (13) Males who will be collected over 1200 mL in total of their blood within 12 months, before and in this test. (14) Females who will be collected over 800 mL in total of their blood within 12 months, before and in this test. (15) Others who have been determined as ineligible for entry, according to the principal/sub investigator's opinions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method